Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sleep Neurology's Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation

Neurotherapeutics(2021)10.1007/s13311-021-01032-7Source: DataRank Database

Sleep Neurology's Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation is a research paper published in Neurotherapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.32)OA: bronzeTopics (47)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Aleksandar Videnović ORCID,Erik K. St. Louis ORCID

Live enrichment

PubMed:33821447 OpenAlex:https://openalex.org/W3145398220

National Institutes of Health

Grant: 5R01NS099055-04

Bright light modulation of non-motor symptoms in Parkinson's disease

National Institutes of Health

Grant: 3UL1TR002377-04S5

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)

National Institutes of Health

Grant: 5R21NS108022-02

Circadian Rhythms Regulation in Pre-Manifest Synucleinopathies

National Institutes of Health

Grant: 5R34AG056639-02

Neuroprotective Treatment Trial Planning in REM Sleep Behavior Disorder

FWCI

0.32

Citation Percentile

0.5%

Citation Trend

2022

2023

2025

bronzeLicense: Elsevier Non-Commercial

journalhttps://link.springer.com/content/pdf/10.1007/s13311-021-01032-7.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13311-021-01032-7.pdf

publisherhttps://link.springer.com/article/10.1007/s13311-021-01032-7/fulltext.html

publisherhttps://api.elsevier.com/content/article/PII:S1878747923011741?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1878747923011741?httpAccept=text/plain

Fields of Study

Sleep and Wakefulness ResearchSleep and related disordersCircadian rhythm and melatonin03 medical and health sciences0302 clinical medicineBehavior TherapyHumansMelatoninPolysomnographySleepSleep Wake Disorders

MeSH Terms

Behavior TherapyHumansMelatoninSleepSleep Wake DisordersPolysomnography

Keywords

Sleep paralysisNarcolepsyNeurologySleep medicineREM sleep behavior disorderRestless legs syndromeNon-rapid eye movement sleepParasomniaMedicineModafinilPsychologyPsychiatrySleep apneaPolysomnographyObstructive sleep apneaSleep disorderInsomniaCataplexyAnesthesiaElectroencephalographySleep Wake DisordersEditorialBehavior TherapyHumansSleepMelatoninCircadian disordersNeurobiologySleep disordered breathingTherapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being